3 results
Approved WMORecruiting
Primary:To compare the efficacy of asciminib versus Investigator selected TKI with respect to the proportion of patients that are in Major Molecular Response at Week 48. To compare the efficacy of asciminib versus Investigator selected TKI, within…
Approved WMOCompleted
To record all reactions of healthy volunteers induced by the use of a homeopathic medicine and placebo.
Approved WMOCompleted
The primary objective of this study is the proof of mechanism and support of dose finding, together with the safety evaluation in patients with clinical evidence of NASH. To gain further insight into clinical effects of AOC3 inhibition on NASH…